Ariad Pharmaceuticals Inc fka ARIA

[piece o mind]

not likely. as you stated, q2 is in the books. that information is already available for privileged investors. just like q1 #s, and europe acceptance. such events have already been taken into account. lifting target expectations from the so called analysts, will do nada for the stock price. Company needs more of a robust event to turn this "Official 2013 P.O.S. stock" upwards.
the best thing to happen for ariads stock price this year, was an offering made to another company...go figure...